Insider Transactions in Q3 2024 at Supernus Pharmaceuticals, Inc. (SUPN)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2024
|
Georges Gemayel Director |
SELL
Open market or private sale
|
Direct |
13,886
-32.74%
|
$430,466
$31.33 P/Share
|
|
Sep 13
2024
|
Georges Gemayel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+30.02%
|
$110,000
$11.46 P/Share
|
|
Sep 03
2024
|
Jack A. Khattar President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,045
-1.07%
|
$341,530
$34.9 P/Share
|
|
Sep 03
2024
|
Jack A. Khattar President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,000
+2.19%
|
-
|
|
Aug 20
2024
|
Padmanabh P. Bhatt Sr. VP of IP, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-5.58%
|
$16,588
$29.57 P/Share
|
|
Aug 20
2024
|
Padmanabh P. Bhatt Sr. VP of IP, CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+10.87%
|
-
|